(Q45760464)

15 December 2017

title

The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge (English)

1 reference

15 December 2017

Herpes simplex virus type 1

main subject

1 reference

H Ghiasi

1

1 reference

15 December 2017

D C Roopenian

2

1 reference

15 December 2017

S Slanina

3

1 reference

15 December 2017

S Cai

4

1 reference

15 December 2017

A B Nesburn

5

1 reference

15 December 2017

S L Wechsler

6

1 reference

15 December 2017

publication date

1 July 1997

1 reference

15 December 2017

published in

Immunology

1 reference

15 December 2017

volume

91

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

430-435

1 reference

15 December 2017

Role of neutralizing antibodies and T-cells in pathogenesis of herpes simplex virus infection in congenitally athymic mice

cites work

1 reference

12 December 2020

Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein

1 reference

12 December 2020

Ocular infection with herpes simplex virus in nonimmune and immune mice

1 reference

12 December 2020

Recurrence of herpes simplex in the mouse requires an intact nerve supply to the skin

1 reference

12 December 2020

Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system

1 reference

12 December 2020

The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection

1 reference

12 December 2020

Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames

1 reference

12 December 2020

Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice

1 reference

12 December 2020

Acute and Recurrent Infection with Herpes Simplex Virus in the Mouse: a Model for Studying Latency and Recurrent Disease

1 reference

12 December 2020

Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody

1 reference

12 December 2020

Role of Lyt-1 positive immune T cells in recovery from herpes simplex virus infection in mice

1 reference

12 December 2020

Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein.

1 reference

12 December 2020

Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology

1 reference

12 December 2020

Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity

1 reference

12 December 2020

Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination

1 reference

12 December 2020

Herpes simplex virus-specific cytolytic T lymphocytes restricted to a normally low responder H-2 allele are protective in vivo

1 reference

12 December 2020

Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

1 reference

12 December 2020

Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants

1 reference

12 December 2020

Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology

1 reference

12 December 2020

Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants

1 reference

12 December 2020

Mice lacking MHC class II molecules

1 reference

12 December 2020

Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.

1 reference

12 December 2020

Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells

1 reference

12 December 2020

Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

1 reference

12 December 2020

Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses

1 reference

12 December 2020

IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice

1 reference

12 December 2020

The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies

1 reference

12 December 2020

The biochemistry and cell biology of antigen processing and presentation

1 reference

12 December 2020

Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice

1 reference

12 December 2020

Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.

1 reference

12 December 2020

Immune response toMycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance

1 reference

12 December 2020

An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.

1 reference

12 December 2020

1 reference

12 December 2020

Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models.

1 reference

12 December 2020

Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge

1 reference

12 December 2020

Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes

1 reference

12 December 2020

10.1046/J.1365-2567.1997.00261.X

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9301533

1 reference

15 December 2017